Ian Ying Woo

Ian Ying Woo

Net worth: 3 M $ as of 2026-07-30

53 year
Health Technology
Consumer Services
Finance

Profile

Ian Ying Woo is currently President, CFO & Executive Director at Everest Medicines Ltd. since 2022, and Executive Director at Everest Medicines (US) Ltd. and Everest Medicines II Ltd. Mr. Woo is also Director at NovaBridge Biosciences starting in 2025 and Operating Partner at CBC Group Co., Ltd. since 2019.
Former roles include Managing Director at Lazard Frères & Co. LLC and Independent Director at Prenetics Global Ltd. Education includes an undergraduate degree from Tufts University in 1994, a graduate degree from the Graduate School of Arts & Sciences at Columbia University in 1998, and an MBA from Columbia Business School in 2003.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-12-30 820,633 ( 0.23% ) 3 M $ 2026-07-30

Ian Ying Woo active positions

CompaniesPositionStart
EVEREST MEDICINES LIMITED President 2018-11-30
NOVABRIDGE BIOSCIENCES Director/Board Member 2025-10-29
CBC Group Co., Ltd.
Corporate Officer/Principal 2018-05-31
Director/Board Member -
Director/Board Member -

Former positions of Ian Ying Woo

CompaniesPositionEnd
PRENETICS GLOBAL LIMITED Director/Board Member -
Corporate Officer/Principal -
See the detail of Ian Ying Woo's experience

Training of Ian Ying Woo

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

97

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Finance

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

CBC Group Co., Ltd.

Health Technology

Health Technology

Finance